The industry discourse around AI has converged on novelty. Every week a new tool is launched into a feed that describes it as a replacement, a disruption, the future. Some of those launches are genuinely significant. Most, soberly examined in production, are not.
The observation we keep making, across the firms we work inside, is that the novelty discourse is largely disconnected from the actual operating condition of most businesses. Most firms are not bottlenecked on the newest tool. They are bottlenecked on the integration of tools they bought twelve months ago and have not yet made part of how the business runs.
There is a difference, often underestimated, between a tool that has been tried and a tool that has been integrated. Trying a tool produces a demo, an anecdote, a slide. Integrating a tool changes how a team works, what it measures, what it no longer has to do by hand, what it now trusts. The first is cheap and common. The second is expensive, slow, and where the actual compounding return lives.
A useful diagnostic, before any conversation about what to buy next, is to audit what is already owned. What tools does the firm have licenses for. How much of that capability is actually being used. Where is the gap between the tool's intended use and its realized use. Where has integration been attempted, stalled, and quietly abandoned.
This is not the conversation the feed rewards. It is, in our experience, the conversation that produces the most value. The firms we admire are the ones that run this audit honestly once a quarter and treat integration as the real work — with acquisition of new tools as a much smaller, much later activity downstream.
There is a lot of attention available for whatever is new. There is significantly less attention paid to whatever is half-integrated. We suggest the reverse allocation.
— Pactag Technologies